Jon OggThese are the top analyst calls of upgrades, downgrades and initiations we have seen from Wall St. research calls this Wednesday morning. AES Corp. (NYSE: AES) named Bear of the Day…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings showing that there have been some significant changes in the positions of the Berkshire…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Changyou.com Ltd. (NASDAQ: CYOU) started as Buy at Citigroup. Eastman Chemical…
The jobs situation may have been weak enough to spur Fed action. (Reuters) As Facebook Inc. (NASDAQ: FB) shares fall, insiders will be able to sell shares. (Reuters) GlaxoSmithKline PLC (NYSE: GSK)…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Broadsoft Inc. (NASDAQ: BSFT) raised to Buy at Goldman Sachs. CafePress Inc. (NASDAQ:…
GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment of HIV infection in adults. While Gilead has been diversifying its products…
Warren Buffett of Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) is often considered the greatest investor in modern times. Some of us think that his status should be one of “The greatest…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for the first quarter of 2012. The top five sellers include drugs from…
The three major US stock indexes opened lower this morning following some lackluster data on the US economy. The Empire State manufacturing data improved, but retail sales posted an unexpected decline (our…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block.…
Updated throughout the day on the 24/7 Wall St. Wire: GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) The Justic Department and HSBC (NYSE: HBC) are…
Douglas A. McIntyre Much of the financial future of Europe is still caught in a web of the political movements of Germany’s Angela Merkel. Today, the possibility that her own party will not support a Spanish…
Douglas A. McIntyre GlaxoSmithKline (NYSE: GSK) will take over Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) A poll from the National Association for Business Economics shows few companies plan to hire new workers. (Reuters)…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech…
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is effectively…
